Pertuzumab,Trastuzumab,Ganetespib,Neratinib,Pembrolizumab,Durvalumab,Olaparib,Cemiplimab,Tucatinib,Paclitaxel,Dostarlimab,Talazoparib,Irinotecan
Merck,GSK,Astrazeneca,Daiichi Sankyo,Amgen,roche,bms
['breast']
part 1: more encouraging #breastcancer research is out! with is first author of a study sharing results from the i-spy2 trial that involved patients with her2-positive breast cancer. #asco22 
Levine Cancer Institute is home to top providers, cutting-edge treatments and groundbreaking clinical trials. Our expert care helps patients heal – and thrive.